Press Releases

March 3, 2020

Thermo Fisher Scientific to Acquire QIAGEN N.V.

Complements leading life sciences offering with innovative sample preparation, assay and bioinformatics technologies

WALTHAM, Mass. and VENLO, Netherlands, March 3, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash.
"We are excited to bring together our complementary offerings to advance our customers' important work, from discovery to diagnostics... This acquisition provides us with the opportunity to leverage our industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs."
Marc Casper | Chairman, President and CEO of Thermo Fisher Scientific


Read full Press Release


Follow us:  
Facebook LinkedIn Twitter